award

A randomized, sequential dose escalation study comparing open-label T2307 to standard of care in candidemia due to Candida auris or other drug-resistant Candida species: A phase 2/3 adaptive design

  • Award Number: R34AI150517

  • ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

  • OPDIV: NIH

  • AWARD CLASS: DISCRETIONARY

  • AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)